Zevra Therapeutics ZVRA
NASDAQ ZVRA
$9.81 -0.50 (-4.85%)
At close: Oct 23, 2026 · 4:00 PM EDT

Zevra Therapeutics (ZVRA) Sale and Maturity of Investments (2016 - 2026)

Updated

Analysis

Zevra Therapeutics (ZVRA) Sale and Maturity of Investments (2016 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Investments Sold (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn -
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 308.00 Mn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn -
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 1.30 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 136.00 Mn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn -
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn -
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 1.03 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 2.12 Bn
10 Zevra Therapeutics 582.14 Mn -230.56 Mn 38.18 Mn 49.25 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 49.25 Mn
Mar 31, 2026 93.97 Mn
Dec 31, 2025 87.50 Mn
Sep 30, 2025 60.50 Mn
Jun 30, 2025 12.50 Mn
Mar 31, 2025 18.00 Mn
Dec 31, 2024 202,000.00
Sep 30, 2024 10.01 Mn
Mar 31, 2024 14.79 Mn
Dec 31, 2023 15.63 Mn
Sep 30, 2023 9.50 Mn
Sep 30, 2022 300,000.00
Mar 31, 2019 3.26 Mn
Dec 31, 2018 7.98 Mn
Sep 30, 2018 463,000.00
Jun 30, 2018 15.68 Mn
Mar 31, 2018 9.23 Mn
Dec 31, 2017 16.05 Mn
Sep 30, 2017 6.11 Mn
Jun 30, 2017 15.34 Mn
API Access

Zevra Therapeutics Sale and Maturity of Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=ZVRA&period=max&api_key=YOUR_API_KEY